FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yu Shen

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Apoptosis

Co-author Network

Publications

TOP 3
Arlene Siefker-Radtke; Dallas L Williams; Yu Shen; Colin P Dinney; H Barton Grossman; Ashish M Kamat; Randall E Millikan
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
Abenaa M Brewster; Scott B Cantor; Melissa Crosby; Wenli Dong; Patricia A Parker; Susan K Peterson; Isabelle Bedrosian; Yu Shen
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
Hao Liu; Jing Qin; Yu Shen
Imputation for semiparametric transformation models with biased-sampling data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yu Shen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arlene Siefker-Radtke; Dallas L Williams; Yu Shen; Colin P Dinney; H Barton Grossman; Ashish M Kamat; Randall E Millikan
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
Cancer 2013;119(3):540-7.
2012: Abenaa M Brewster; Scott B Cantor; Melissa Crosby; Wenli Dong; Patricia A Parker; Susan K Peterson; Isabelle Bedrosian; Yu Shen
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
Cancer 2012;118(22):5637-43.
2012: Hao Liu; Jing Qin; Yu Shen
Imputation for semiparametric transformation models with biased-sampling data.
Lifetime data analysis 2012;18(4):470-503.
2012: Jeffrey M Albert; Thomas A Buchholz; Sharon H Giordano; Karen E Hoffman; Diane D Liu; I-Wen Pan; Yu Shen; Ya-Chen Tina Shih; Benjamin D Smith
Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(23):2837-43.
2012: Woonyoung Choi; Colin Dinney; I-Ling Lee; Lauren Marquis; David J McConkey; Jay B Shah; Yu Shen; Robert S Svatek; Mai Tran; Sijin Wen; Dasom Yu; Liana Adam; Arlene Siefker-Radtke
p63 expression defines a lethal subset of muscle-invasive bladder cancers.
PloS one 2012;7(1):e30206.
2011: David Rogers; Yu Shen; Douglas D Boyd; Sharon Cooper; Erin E Fox; Marc Goldhagen; Deborah J Del Junco
Prostate cancer incidence in U.S. Air Force aviators compared with non-aviators.
Aviation, space, and environmental medicine 2011;82(11):1067-70.
2009: Yu Shen; Wenli Dong; Barry W Feig; Peter M Ravdin; Richard L Theriault; Sharon H Giordano
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004.
Cancer 2009;115(10):2041-51.
2009: John W Davis; David W Chang; Pierre Chevray; Run Wang; Yu Shen; Sijin Wen; Curtis A Pettaway; Louis L Pisters; David A Swanson; Lydia T Madsen; Nelda Huber; Patricia Troncoso; R Joseph Babaian; Christopher G Wood
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.
European urology 2009;55(5):1135-43.
2009: Charlotte Hsieh Ahern; Yu Shen
Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):718-25.
2009: Vitaly Margulis; Surena F Matin; Nizar M Tannir; Pheroze Tamboli; Yu Shen; Marisa Lozano; David A Swanson; Eric Jonasch; Christopher G Wood
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.
Urology 2009;73(2):337-41.
2008: Yu Shen; Joseph P Costantino; Jing Qin
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer.
Journal of the National Cancer Institute 2008;100(20):1448-53.
2008: Loleta D Harris; Jorge De La Cerda; Tomasz Tuziak; Daniel G Rosen; Lianchun Xiao; Yu Shen; Anita L Sabichi; Bogdan Czerniak; H Barton Grossman
Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray.
Molecular carcinogenesis 2008;47(9):678-85.
2008: Wenli Dong; Donald A Berry; Therese B Bevers; Shu-Wan Kau; Limin Hsu; Richard L Theriault; Yu Shen
Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(5):1096-103.
2007: Miloslav Beran; Sijin Wen; Yu Shen; Francesco Onida; Jaroslav Jelinek; Jorge Cortes; Francis Giles; Andrew Lamb
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System.
Leukemia & lymphoma 2007;48(6):1150-60.
2007: Yu Shen; Wenli Dong; Francisco J Esteva; Shu-Wan Kau; Richard L Theriault; Therese B Bevers
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?
Breast cancer research and treatment 2007;102(3):347-56.
2007: Padmanee Sharma; Yu Shen; Sijin Wen; Sachiko Yamada; Achim A Jungbluth; Sacha Gnjatic; Dean F Bajorin; Victor E Reuter; Harry W Herr; Lloyd J Old; Eiichi Sato
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):3967-72.
2007: Weiwei Feng; Lanlan Shen; Sijin Wen; Daniel G Rosen; Jaroslav Jelinek; Xin Hu; Shaoyi Huan; Miao Huang; Jinsong Liu; Aysegul A Sahin; Kelly K Hunt; Robert C Bast; Yu Shen; Jean-Pierre J Issa; Yinhua Yu
Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
Breast cancer research : BCR 2007;9(4):R57.
2006: Padmanee Sharma; Yu Shen; Sijin Wen; Dean F Bajorin; Victor E Reuter; Lloyd J Old; Achim A Jungbluth
Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5442-7.
2006: Donald A Berry; Lurdes Y T Inoue; Yu Shen; John Venier; Debbie Cohen; Melissa L Bondy; Richard Theriault; Mark F Munsell
Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
Journal of the National Cancer Institute. Monographs 2006;(36):30-6.
2005: Yu Shen; Xuelin Huang
Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial.
Biometrics 2005;61(4):992-9.
2005: Ashish M Kamat; Kenneth M Jacobsohn; Patricia Troncoso; Yu Shen; Sijin Wen; R Joseph Babaian
Validation of criteria used to predict extraprostatic cancer extension: a tool for use in selecting patients for nerve sparing radical prostatectomy.
The Journal of urology 2005;174(4 Pt 1):1262-5.
2005: Yu Shen; Marvin Zelen
Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution.
Biostatistics (Oxford, England) 2005;6(4):604-14.
2005: Hesham M Amin; Y Yang; Yu Shen; Elihu H Estey; Francis Giles; Sherry A Pierce; Hagop M Kantarjian; Susan M O'Brien; Iman Jilani; Maher Albitar
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
Leukemia 2005;19(9):1567-72.
2005: Yu Shen; Ying Yang; Lurdes Y T Inoue; Mark F Munsell; Anthony B Miller; Donald A Berry
Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Journal of the National Cancer Institute 2005;97(16):1195-203.
2005: Guosheng Yin; Yu Shen
Adaptive design and estimation in randomized clinical trials with correlated observations.
Biometrics 2005;61(2):362-9.
2005: B Nebiyou Bekele; Yu Shen
A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial.
Biometrics 2005;61(2):343-54.
2005: Dan Leibovici; Andrew K Lee; Rex M Cheung; Philippe E Spiess; Deborah A Kuban; Charles J Rosser; Yu Shen; Ying Yang; Ramsey Chichakli; Louis L Pisters
Symptomatic local recurrence of prostate carcinoma after radiation therapy.
Cancer 2005;103(10):2060-6.
2005: Yu Shen; Giovanni Parmigiani
A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):529-32.
2005: Darren W Davis; Ryan Takamori; Chandrajit P Raut; Henry Q Xiong; Roy S Herbst; Walter M Stadler; John V Heymach; George D Demetri; Asif Rashid; Yu Shen; Sijin Wen; James L Abbruzzese; David J McConkey
Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):678-89.
2005: Guosheng Yin; Yu Shen
Self-designing trial combined with classical group sequential monitoring.
Journal of biopharmaceutical statistics 2005;15(4):667-75.
2004: Ricardo F Sánchez-Ortiz; Lydia T Madsen; Carlos Bermejo; Sijin Wen; Yu Shen; David A Swanson; Christopher G Wood
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?
Cancer 2004;101(10):2195-201.
2004: Arlene Siefker-Radtke; Colin P N Dinney; Neil A Abrahams; Cesar Moran; Yu Shen; Louis L Pisters; H Barton Grossman; David A Swanson; Randall E Millikan
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.
The Journal of urology 2004;172(2):481-4.
2004: Qinglong Hu; Amanda L Dey; Ying Yang; Yu Shen; Iman Jilani; Elihu H Estey; Hagop M Kantarjian; Francis Giles; Maher Albitar
Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
Cancer 2004;100(9):1884-91.
2004: Ashish M Kamat; Takashi Karashima; Darren W Davis; Laura M Lashinger; Menashe Bar-Eli; Randall Millikan; Yu Shen; Colin P N Dinney; David J McConkey
The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.
Molecular cancer therapeutics 2004;3(3):279-90.
2004: Joel W Slaton; Randall Millikan; Keiji Inoue; Takashi Karashima; Bogdan Czerniak; Yu Shen; Ying Yang; William F Benedict; Colin P N Dinney
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.
The Journal of urology 2004;171(2 Pt 1):570-4.
2004: Darren W Davis; Yu Shen; Nizar A Mullani; Sijin Wen; Roy S Herbst; Michael O'Reilly; James L Abbruzzese; David J McConkey
Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):33-42.
2004: Arlene Siefker-Radtke; Garrett L Walsh; Louis L Pisters; Yu Shen; David A Swanson; Christopher J Logothetis; Randall E Millikan
Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience.
The Journal of urology 2004;171(1):145-8.
2003: Arlene Siefker-Radtke; Jason Gee; Yu Shen; Sijin Wen; Danai D Daliani; Randall E Millikan; Louis L Pisters
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
The Journal of urology 2003;169(4):1295-8.
2002: Maher Albitar; Taghi Manshouri; Yu Shen; Diane Liu; Miloslav Beran; Hagop M Kantarjian; Anna Rogers; Iman Jilani; Chung-Wu Lin; Sherry Pierce; Emil J Freireich; Elihu H Estey
Myelodysplastic syndrome is not merely "preleukemia".
Blood 2002;100(3):791-8.
2002: R K S Phillips; MH Wallace; Patrick M Lynch; Ernest T Hawk; Gary B Gordon; B P Saunders; N Wakabayashi; Yu Shen; Stuart O Zimmerman; L Godio; M Rodrigues-Bigas; Li-Kuo Su; J Sherman; Gary J Kelloff; Bernard Levin; G Steinbach
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
Gut 2002;50(6):857-60.
2002: Lanlan Shen; NITA AHUJA; Yu Shen; Nagy A Habib; Minoru Toyota; Asif Rashid; Jean-Pierre J Issa
DNA methylation and environmental exposures in human hepatocellular carcinoma.
Journal of the National Cancer Institute 2002;94(10):755-61.
2002: Sima Jeha; Franklin O Smith; Elihu Estey; Yu Shen; Diane Liu; Taghi Manshouri; Maher Albitar
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels.
Leukemia research 2002;26(4):399-402.
2002: Paula M Termuhlen; Bridget Sweeney-Gotsch; Russell S Berman; Lee M Ellis; Corazon D Bucana; Yu Shen; Karen R Cleary; David J McConkey
Increased apoptosis in metastatic human colonic adenocarcinomas.
Cancer biology & therapy 2002;1(1):58-63.
2002: Raymond Lai; Elihu Estey; Yu Shen; Simona Despa; Andrew Lamb; Miloslav Beran; Taghi Maushouri; Robert C Quackenbuch; Michael Keating; Maher Albitar
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.
Cancer 2002;94(1):14-7.
2001: Yu Shen; D Wu; Marvin Zelen
Testing the independence of two diagnostic tests.
Biometrics 2001;57(4):1009-17.
2001: Miloslav Beran; Yu Shen; Andrew Lamb; Susan O'Brien; Charles Koller; Francis Giles; Jorge Cortes; Deborah A Thomas; Stefan Faderl; Simona Despa; Elihu H Estey
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.
Cancer 2001;92(8):1999-2015.
2001: Yu Shen; Jianwen Cai
Maximum of the weighted Kaplan-Meier tests with application to cancer prevention and screening trials.
Biometrics 2001;57(3):837-43.
2001: Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller; Miloslav Beran; Deborah Thomas; Michael Keating; Andrew Lamb
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.
Cancer 2001;92(1):7-14.
2001: Francis Giles; Yu Shen; Hagop M Kantarjian; Martin Korbling; Susan O'Brien; Paolo Anderlini; Michele Donato; Sherry Pierce; Michael J Keating; Emil J Freireich; Elihu Estey
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival.
Leukemia & lymphoma 2001;42(1-2):67-73.
2000: G Steinbach; Patrick M Lynch; R K S Phillips; MH Wallace; Ernest T Hawk; Gary B Gordon; N Wakabayashi; B Saunders; Yu Shen; T Fujimura; Li-Kuo Su; Bernard Levin; J Abbruzzese; R N DuBois; L Godio; W N Hittelman; S L Jester; K L King; S Patterson; M A Rodriguez-Bigas; M Schumacher; J W Sherman; S Zimmerman; G Kelloff
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
The New England journal of medicine 2000;342(26):1946-52.
2000: Peter F Thall; R M Simon; Yu Shen
Approximate Bayesian evaluation of multiple treatment effects.
Biometrics 2000;56(1):213-9.
2000: Li-Ying Yang; Li Li; Hong Jiang; Yu Shen; William Plunkett
Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):773-81.
2000: Elihu H Estey; Yu Shen; Peter F Thall
Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB.
Blood 2000;95(1):72-7.
1999: Yu Shen; SC Cheng
Confidence bands for cumulative incidence curves under the additive risk model.
Biometrics 1999;55(4):1093-100.
1999: Frank A Sinicrope; Michael G Lemoine; L Xi; Patrick M Lynch; Karen R Cleary; Yu Shen; Marsha L Frazier
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.
Gastroenterology 1999;117(2):350-8.
1999: Yu Shen; Lloyd Fisher
Statistical inference for self-designing clinical trials with a one-sided hypothesis.
Biometrics 1999;55(1):190-7.
1998: Frank A Sinicrope; G Roddey; Michael G Lemoine; S Ruan; L Clifton Stephens; Marsha L Frazier; Yu Shen; Weiqing Zhang
Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1251-61.
1998: D Seong; Peter F Thall; Hagop M Kantarjian; Moshe Talpaz; J Swantkowski; Jingping Xu; Yu Shen; Armand B. Glassman; Louis S Ramagli; Michael J Siciliano
Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(4):861-7.
1996: Frank A Sinicrope; G Roddey; Timothy J McDonnell; Yu Shen; Karen R Cleary; L Clifton Stephens
Increased apoptosis accompanies neoplastic development in the human colorectum.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(12):1999-2006.